المؤلفون: Lillian M Smyth (10284013), Gerald Batist (387752), Funda Meric-Bernstam (478258), Peter Kabos (3570254), Iben Spanggaard (3948713), Ana Lluch (103419), Komal Jhaveri (10284015), Andrea Varga (514916), Andrea Wong (848459), Alison M. Schram (3772174), Helen Ambrose (10284018), T. Hedley Carr (423605), Elza C de Bruin (9134279), Carolina Salinas-Souza (10284021), Andrew Foxley (10284024), Joana Hauser (10284027), Justin PO Lindemann (10284030), Rhiannon Maudsley (10284033), Robert McEwen (108964), Michele Moschetta (10284035), Myria Nikolaou (10284038), Gaia Schiavon (125070), Pedram Razavi (8906453), Udai Banerji (121001), José Baselga (4431208), David M. Hyman (737881), Sarat Chandarlapaty (90196)

مصطلحات موضوعية: Cancer Genetics, Oncology and Carcinogenesis not elsewhere classified, Clinical Pharmacology and Therapeutics, phase I trial, capivasertib, fulvestrant, metastatic breast cancer, PTEN-mutant, Estrogen-Receptor-Positive Breast Cancer

Relation: https://figshare.com/articles/online_resource/Metadata_record_for_the_article_Capivasertib_a_selective_AKT_kinase_inhibitor_in_combination_with_fulvestrant_in_PTEN-mutant_ER-positive_metastatic_breast_cancer_a_non-randomized_controlled_trial/14192345

الاتاحة: https://doi.org/10.6084/m9.figshare.14192345

المؤلفون: Apostolia Maria Tsimberidou (10034892), David S. Hong (8737077), Siqing Fu (160695), Daniel D. Karp (10034894), Sarina Piha-Paul (5984330), Merrill S. Kies (10034897), Vinod Ravi (10034900), Vivek Subbiah (353745), Sunil M. Patel (10034904), Shi-Ming Tu (714480), Filip Janku (160679), John Heymach (5343626), Amber Johnson (267652), Carrie Cartwright (8204421), Li Zhao (147498), Jianhua Zhang (6347), Donald A. Berry (9239313), David J Vining (10034906), Andrew Futreal (561653), Vincent A. Miller (3594653), Funda Meric-Bernstam (478258)

مصطلحات موضوعية: Medicine, Cancer, Biological Techniques, Cancer Cell Biology, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Biological Sciences not elsewhere classified, precision medicine, personalized medicine, clinical trial, next-generation sequencing, genomic profiling, metastatic cancer, overall survival, progression- free survival

Relation: https://figshare.com/articles/online_resource/Metadata_supporting_the_article_Precision_Medicine_Preliminary_Results_from_the_Initiative_for_Molecular_Profiling_and_Advanced_Cancer_Therapy_2_IMPACT_2_Study/13643420

الاتاحة: https://doi.org/10.6084/m9.figshare.13643420.v1

المؤلفون: Kyaw Z. Thein (11887073), Sarina A. Piha-Paul (8737080), Apostolia Tsimberidou (341493), Daniel D. Karp (10034894), Filip Janku (160679), Siqing Fu (160695), Vivek Subbiah (353745), David S. Hong (8737077), Timothy A. Yap (11887076), Jatin Shah (101993), Denái R. Milton (11887079), Lacey McQuinn (11887082), Jing Gong (105828), Yanyan Tran (11887085), Brett W. Carter (11887088), Rivka Colen (11887091), Funda Meric-Bernstam (478258), Aung Naing (160702)

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Space Science, Biological Sciences not elsewhere classified, Selinexor (KPT 330), Carboplatin, Irinotecan, FOLFIRI, Doxorubicin and cyclophosphamide, Capecitabine and oxaliplatin (XELOX)

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Selinexor_in_combination_with_standard_chemotherapy_in_patients_with_advanced_or_metastatic_solid_tumors/17704589

الاتاحة: https://doi.org/10.6084/m9.figshare.17704589.v1